India's drug barons
Hungry for growth, Indian drugs firms are looking to Europe as a haven of potential acquisition targets. Despite some cultural and business hurdles, more deals are likely, reports mergermarket.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts